About Us
Careers
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Your main specialty
Adult & Family Medicine
Allergy, Asthma, Immunology
Anesthesiology
Cardiology
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
Playback speed
0.5x
0.75x
1x (Normal)
1.25x
1.5x
1.75x
2x
10 seconds
Cancer Cell Metabolic Adaptations to the Leptomeningeal Space
By
MSKCC 2nd Annual Symposium on Advanced Therapeutics for Brain Metastasis
FEATURING
Adrienne Boire
By
MSKCC 2nd Annual Symposium on Advanced Therapeutics for Brain Metastasis
FEATURING
Adrienne Boire
0 views
April 30, 2024
Comments
0
Login to view comments.
Click here to Login
Featured Video
06:14
Lilly Medical Affairs
CDK4/6 Inhibitors as First-Line Treatment for HR+, HER2- MBC
Feat.
J. O’Shaughnessy
Featured Video
02:58
Lilly Medical Affairs
A Heterogenous Disease with Varied Clinical Outcomes: HR+/HER2- MBC
Feat.
J. O’Shaughnessy
Recommended
AUTOPLAY
ON
Related
Newest
25:08
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Breast Cancer Highlights - Monday Morning Practice
Feat.
S. Tolaney,
H. Rugo
12:35
Insights from 2023 SABCS
SABCS 2023 Summary: "What Is the Appropriate 1L Therapy for ER+…
Feat.
S. Tolaney,
H. Rugo
16:02
Penn Medicine's 11th Neuro-Oncology Brain Tumor Symposium 2024
cfDNA for Liquid Biopsy for Patients With Glioblastoma
Feat.
S. Bagley
18:47
Total Health
Updates in the Management of NSCLC: Systemic Therapy Year in Review
Feat.
W. Iams
36:18
Insights from ESMO Breast 2024 Annual Meeting
Metastatic Breast Cancer Comprehensive Review: ESMO Breast 2024 Awar…
Feat.
H. Rugo
12:46
Stanford Medicine
FDA Approval of Lifileucel for Unresectable or Metastatic Melanoma: …
Feat.
A. Betof Warner
06:10
Insights from ESMO Breast 2024 Annual Meeting
ESMO Breast 2024 Summary: "Is There a Role for Combining ADCs W…
Feat.
S. Tolaney
49:07
SABCS 2022 Conference Coverage
SABCS 2022 Expert Panel Discussion: Practice-Changing Updates
Feat.
J. O'Shaughnessy,
S. Tolaney,
S. Hurvitz,
H. Rugo
07:50
Oncology Data Advisor
ESMO 2023 Insights: "Real-World Use Patterns, Effectiveness, &a…
Feat.
K. Kalinsky
24:14
Masterclasses in Dermatology
Advances in the Treatment of Melanoma
Feat.
D. Fisher
33:44
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Expert Recap: "Metastatic Breast Cancer Deep Dive &a…
Feat.
S. Tolaney,
H. Rugo
36:14
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Lung Cancer Highlights: Top Abstracts Including BEAT-SC, …
Feat.
B. Halmos
17:33
Henry Friedman
Overview and Updates in Brain Tumors
17:35
Insights from 2023 SABCS
SABCS 2023 Summary: "Top 5 Studies Including KATHERINE & HE…
Feat.
P. Tarantino
10:01
AAD 2024 Insights
AAD 2024 Insights: The Latest Advances in the Treatment of Melanoma
Feat.
V. Sondak
10:09
Insights from ESMO Breast 2024 Annual Meeting
ESMO Breast 2024 Insights: "Pooled Analysis of T-DXd Retreatmen…
Feat.
H. Rugo
17:34
ecancer
Recent NSCLC Updates Including PAPILLON, CHECKMATE 77T, and KEYNOTE-…
Feat.
L. Raez
05:35
Insights from ESMO Breast 2024 Annual Meeting
ESMO Breast 2024 Insights: "IMpassion132 Trial - Is There a Rol…
Feat.
S. Tolaney
16:57
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Precision Medicine Highlights: LAURA and CROWN Trials (NS…
Feat.
V. Subbiah
21:37
Dana-Farber Cancer Institute
Standard Treatments for HR+/HER2- mBC in 2023
Feat.
S. Sammons
